FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Benefits, Dosage & Before After Results The FDA's Ban of Therapeutic Peptides: A Threat to Health Freedom Slim 'n Sleek